Skip to content

Company information lookup

CLINUVEL PHARMACEUTICALS LIMITED (CUV)

Clinuvel Pharmaceuticals Ltd. is a leading and innovative Australian company focused on the development of SCENESSE¿ (afamelanotide), its proprietary first-in-class drug, as a photoprotective in a range of UV and light related skin disorders and as a repigmentation therapy in the common skin disorder vitiligo.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
CUV 1.630 1.87% 1.565 1.630 1.600 1.630 1.600 13,000

CLINUVEL PHARMACEUTICALS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code CUV
Securities
Official Listing Date 13 February, 2001
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.clinuvel.com
Registered Office Address Level 14, 190 Queen Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone 61 3 9660 4900
Head Office Fax 61 3 9660 4999
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Stanley McLiesh (Non Exec. Chairman, Non Exec. Director)
Mr Philippe Wolgen (CEO)
Mr Elia Ishag (Non Exec. Director)
Ms Brenda Shanahan (Non Exec. Director)
Mr Jack Wood (Non Exec. Director)
Mr Darren Keamy (CFO)
Company Secretary Mr Darren Keamy
Principal Activities Clinuvel Pharmaceuticals Ltd. is a leading and innovative Australian company focused on the development of SCENESSE¿ (afamelanotide), its proprietary first-in-class drug, as a photoprotective in a range of UV and light related skin disorders and as a repigmentation therapy in the common skin disorder vitiligo.

CLINUVEL PHARMACEUTICALS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
17/04/2014 asterix Appendix 4C - quarterly 5 PDF
14/04/2014   Lapse and Forfeit of Unlisted Conditional Performance Rights 1 PDF
14/04/2014   Clinuvel Newsletter April 2014 2 PDF
20/03/2014   SCENESSE data to feature at American Academy of Dermatology 2 PDF
26/02/2014 asterix Half Yearly Report and Accounts 12 PDF
10/02/2014 asterix Phase II study starts in skin disorder Hailey-Hailey Disease 4 PDF
04/02/2014   Clinuvel Newsletter 3 PDF
31/01/2014 asterix Appendix 4C - quarterly 5 PDF
30/01/2014 asterix EMA review of SCENESSE extended to mid-2014 2 PDF
08/01/2014   Letter to Shareholders 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 1.630 1.87% 1.630 1.600 13,000
15 Apr 2014 1.600 0% 1.600 1.600 12,314
14 Apr 2014 1.600 -1.84% 1.650 1.600 29,270
11 Apr 2014 1.630 -1.21% 1.630 1.630 502,200
10 Apr 2014 1.650 -0.9% 1.665 1.650 12,482

* Volume of shares shown represents only those shares traded on ASX.

CLINUVEL PHARMACEUTICALS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security CUV. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security CUV

Warrants & Structured Products

No warrants & Structured Products are available over the security CUV

ASX CFDs

No Contracts For Differences are available over the security CUV